He aha ʻo Lazertinib: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau maʻi maʻi hou ʻo Lazertinib i hoʻolālā ʻia e mālama i kekahi mau ʻano maʻi maʻi maʻi māmā. Hana kēia lāʻau lapaʻau waha ma ka pale ʻana i nā protein kikoʻī e kōkua i nā sela maʻi maʻi e ulu a laha, e hāʻawi ana i ka manaʻolana no nā maʻi me ka maʻi maʻi maʻi māmā non-small cell (NSCLC) i loaʻa nā loli genetic kikoʻī.

Inā ua kau ʻia ʻo lazertinib iā ʻoe a i ʻole kekahi mea aloha, he mau nīnau paha kāu e pili ana i ke ʻano o kāna hana, ka mea e manaʻo ai, a pehea e lawe ai me ka palekana. E hele kākou i nā mea a pau e pono ai ʻoe e ʻike e pili ana i kēia lāʻau lapaʻau koʻikoʻi ma ke ʻano e manaʻo ai he hiki ke mālama a maopopo.

He aha ʻo Lazertinib?

He lāʻau lapaʻau i manaʻo ʻia ʻo Lazertinib e pili ana i kahi papa o nā lāʻau i kapa ʻia ʻo EGFR inhibitors. Ua hoʻolālā ʻia e mālama i nā sela maʻi maʻi māmā i loaʻa nā loli genetic, ʻo ia hoʻi ka EGFR T790M mutation e hiki ke ulu ma hope o ka mālama ʻana me nā lāʻau maʻi maʻi ʻē aʻe.

E noʻonoʻo iā lazertinib ma ke ʻano he mea hana pololei loa e manaʻo ana i nā wahi nāwaliwali kikoʻī i nā sela maʻi maʻi. ʻAʻole like me ka chemotherapy kuʻuna e pili ana i nā sela like ʻole i kou kino, ua kālele ʻo lazertinib i nā protein kikoʻī e hoʻoulu ai i kāu ʻano maʻi maʻi. ʻO kēia ala i manaʻo ʻia he liʻiliʻi nā hopena ʻaoʻao i hoʻohālikelike ʻia me nā lāʻau maʻi maʻi ākea.

Hele mai ka lāʻau lapaʻau ma ke ʻano he papa waha, ʻo ia hoʻi hiki iā ʻoe ke lawe ma ka home ma mua o ka pono e kipa i kahi kikowaena lapaʻau no nā infusions. Hiki i kēia mea maʻalahi ke kōkua i ka mālama ʻana i kou ola i ka wā e loaʻa ai ka lāʻau maʻi maʻi maikaʻi.

No ke aha e hoʻohana ʻia ai ʻo Lazertinib?

Hoʻohana nui ʻia ʻo Lazertinib e mālama i ka maʻi maʻi māmā non-small cell (NSCLC) i nā maʻi i loaʻa nā mutations EGFR kikoʻī i kā lākou mau ʻōpū. E hoʻāʻo kāu kauka i kāu ʻiʻo maʻi maʻi e hōʻoia i kēia mau loli genetic ma mua o ke kau ʻana i kēia lāʻau.

Hoʻohana pinepine ʻia ka lāʻau lapaʻau ke holomua kāu maʻi maʻi ma hope o ka mālama ʻana me nā mea pale EGFR ʻē aʻe e like me erlotinib a i ʻole gefitinib. He mea maikaʻi loa ia e kūʻē i ka mutation kūʻē T790M e ulu pinepine ana i loko o nā pūnaewele maʻi maʻi maʻi maʻi ma luna o ka manawa.

I kekahi mau hihia, hiki ke hoʻohana ʻia ka lazertinib ma ke ʻano he lapaʻau mua no ka maʻi maʻi maʻi maʻi maʻi hou me kekahi mau mutations EGFR. E hoʻoholo kāu oncologist i ka manawa maikaʻi loa e pili ana i nā ʻano maʻi maʻi kikoʻī a me ke kūlana olakino holoʻokoʻa.

Pehea e hana ai ʻo Lazertinib?

Hana ʻo Lazertinib ma ka pale ʻana i ka protein EGFR, ʻo ia hoʻi ka epidermal growth factor receptor. Kōkua maʻamau kēia protein i nā pūnaewele olakino e ulu a māhele, akā i loko o nā pūnaewele maʻi maʻi me nā mutations EGFR, lilo ia i mea hana nui a hoʻokele i ka ulu ʻana o ka maʻi.

Ke pale ʻo lazertinib i kēia protein, ʻoki maoli ia i ka hōʻailona ulu nui o nā pūnaewele maʻi maʻi. Me ka ʻole o kēia hōʻailona, ​​ʻaʻole hiki i nā pūnaewele maʻi maʻi ke hoʻonui wikiwiki a hiki ke make. ʻO kēia ke kumu i manaʻo ʻia ai ʻo lazertinib he

ʻAʻole pono ʻoe e lawe i ka lazertinib me ka waiū a i ʻole e pale i kekahi mau meaʻai, akā he maikaʻi ka mālama ʻana i ka meaʻai olakino a kaulike i ka wā e mālama ʻia ai ka maʻi kanesa. Manaʻo kekahi poʻe maʻi he mea kōkua ka lawe ʻana me kahi meaʻai māmā e pale ai i ka ʻōpū, ʻoiai ʻaʻole pono kēia.

E mālama i kāu lāʻau lapaʻau ma ka lumi wela, mai ka wai a me ka wela. E mālama i loko o kāna pahu mua a mai hiki i nā keiki a me nā holoholona.

Pehea ka lōʻihi e lawe ai au i ka Lazertinib?

E hoʻomau ʻoe i ka lawe ʻana i ka lazertinib no ka lōʻihi e hana pono ana a ke ʻae nei ʻoe iā ia. Hiki i kēia ke mau mahina a i ʻole mau makahiki, ma muli o ke ʻano o ka pane ʻana o kāu maʻi kanesa i ka lāʻau lapaʻau.

E nānā kāu kauka i kou holomua ma o nā scans maʻamau a me nā hoʻokolohua koko e loiloi i ka maikaʻi o ka hana ʻana o ka lāʻau lapaʻau. E nānā pū lākou i nā hopena ʻaoʻao e koi ai i nā hoʻoponopono ʻana i ka dosis a i ʻole nā ​​hoʻomaha lapaʻau.

He mea pilikino loa ka lōʻihi o ka mālama ʻana a pili i nā mea e like me ke ʻano o ka pane ʻana o kāu maʻi kanesa, kou olakino holoʻokoʻa, a me ka maikaʻi o kou ʻae ʻana i ka lāʻau lapaʻau. Lawe kekahi poʻe maʻi i ka lazertinib no nā manawa lōʻihi me nā hopena maikaʻi, ʻoiai pono nā mea ʻē aʻe e hoʻololi i nā lāʻau lapaʻau like ʻole inā holomua kā lākou maʻi kanesa.

Mai hooki i ka lawe ʻana i ka lazertinib me ka kūkākūkā ʻole ʻana me kāu oncologist mua, ʻoiai inā ʻoe e ʻoi aku ka maikaʻi. Pono ka mālama ʻana i ka maʻi kanesa i ka mālama ʻana i ka lāʻau lapaʻau e hōʻoia i nā hopena maikaʻi loa.

He aha nā hopena ʻaoʻao o Lazertinib?

E like me nā lāʻau lapaʻau maʻi kanesa a pau, hiki i ka lazertinib ke hana i nā hopena ʻaoʻao, ʻoiai ua ʻae maikaʻi ka nui o nā maʻi. Hiki ke mālama ʻia nā hopena ʻaoʻao maʻamau me ka mālama kūpono a me ka nānā ʻana.

Eia nā hopena ʻaoʻao āu e ʻike ai, a e hoʻomanaʻo ʻo ka loaʻa ʻana o kekahi mau hopena ʻaoʻao ʻaʻole ia he manaʻo ʻaʻole hana maikaʻi ka lāʻau lapaʻau iā ʻoe:

• Ka maʻi palahē, hiki ke mālama ʻia me nā lāʻau lapaʻau i kūʻai ʻia a me nā hoʻololi ʻana i ka meaʻai
• Pāhū ʻili a i ʻole nā puʻupuʻu e like me ka ʻākena, ʻoi loa ma kou maka a me ke kino luna
• Luhi a i ʻole ka manaʻo e luhi pinepine ana ma mua o ka maʻamau
• Nāwaliwali a i ʻole ka ʻoluʻolu o ka ʻōpū
• Hoʻēmi ʻia ka ʻai
• Nā loli o nā kui, me ka palupalu a i ʻole ka mumū a puni nā moena kui
• Nā ʻeha o ka waha a i ʻole ka waha maloʻo

He maʻalahi a maʻalahi paha kēia mau hopena ʻaoʻao maʻamau a pinepine e hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau. Hiki i kāu hui mālama ola ke hāʻawi i nā hoʻolālā kikoʻī e mālama i kēlā me kēia o kēia mau mea inā loaʻa lākou.

Hiki ke loaʻa kekahi mau hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi, ʻoiai he kakaikahi lākou. Pākuʻi ʻia kēia i ka mumū o ka māmā (pneumonitis), nā hopena ʻili koʻikoʻi, nā pilikia o ke ake, a me nā loli o ka puʻuwai. E nānā pono kāu kauka iā ʻoe no kēia mau mea ma o nā loiloi maʻamau a me nā hoʻokolohua lab.

Inā loaʻa iā ʻoe ka maʻi palahē koʻikoʻi, ka pilikia o ka hanu ʻana, nā hopena ʻili koʻikoʻi, a i ʻole kekahi mau hōʻailona e hopohopo ai ʻoe, e hoʻokaʻaʻike koke i kāu hui mālama ola. Aia lākou ma laila e kōkua iā ʻoe e mālama i nā pilikia e kū mai ana i ka wā o ka mālama ʻana.

ʻO wai ka mea pono ʻole e lawe iā Lazertinib?

ʻAʻole kūpono ʻo Lazertinib no nā mea a pau, a e loiloi pono kāu kauka inā kūpono ia no ʻoe e pili ana i kāu mōʻaukala olakino a me ke kūlana olakino o kēia manawa.

ʻAʻole pono ʻoe e lawe iā lazertinib inā he maʻi ʻoe iā ia a i ʻole kekahi o kāna mau meaʻai. E nānā kāu kauka i ka papa inoa piha o nā meaʻai me ʻoe inā he maʻi lāʻau lapaʻau kou.

Pono paha ka poʻe me kekahi mau maʻi puʻuwai i ka nānā ʻana kūikawā a i ʻole ʻaʻole paha he moho no ka lazertinib, no ka mea, hiki iā ia ke hoʻopilikia i ka puʻuwai. E hana paha kāu kauka i kahi EKG (hoʻokolohua puʻuwai) ma mua o ka hoʻomaka ʻana i ka mālama ʻana a me ka manawa i ka wā o ka mālama ʻana.

Inā hāpai ʻoe a i ʻole e hānai ana i ka waiū, ʻaʻole i ʻōlelo ʻia ka lazertinib no ka mea hiki iā ia ke hōʻino i kahi pēpē e ulu ana. Pono nā wāhine o ka makahiki hānau ke hoʻohana i ka mana hānau kūpono i ka wā o ka mālama ʻana a no kekahi mau pule ma hope o ka pau ʻana o ka lāʻau.

ʻO ka poʻe me nā pilikia ate a i ʻole nā pilikia kīkī koʻikoʻi e pono paha i nā hoʻoponopono ʻana i ka lāʻau a i ʻole ʻaʻole hiki ke lawe palekana i ka lazertinib. E nānā kāu kauka i kāu hana ate a me ka hana kīkī ma mua a i ka wā o ka mālama ʻana.

Inoa Brand Lazertinib

Hoʻolaha ʻia ʻo Lazertinib ma lalo o ka inoa brand Lazertinib i kekahi mau ʻāina, ʻoiai ʻokoʻa ka loaʻa ʻana ma ka ʻāina. I kekahi mau mākeke, loaʻa paha ia ma lalo o nā inoa brand like ʻole a i ʻole e komo ana i nā hoʻokolohua lapaʻau.

He mea hou ka lāʻau lapaʻau i hoʻohālikelike ʻia me nā mea pale EGFR ʻē aʻe, no laila ke hoʻonui nei kona loaʻa ʻana o ka ʻoihana ma ka honua holoʻokoʻa. E ʻike kāu oncologist inā loaʻa ka lazertinib ma kou wahi a ma lalo o ka inoa hea.

Inā ʻaʻole loaʻa ka lazertinib ma kahi āu e noho ai, hiki i kāu kauka ke kōkua iā ʻoe e komo iā ia ma o nā hoʻokolohua lapaʻau a i ʻole nā papahana komo kūikawā. Mai kānalua e nīnau e pili ana i kāu mau koho a pau.

Nā Koho ʻē aʻe o Lazertinib

Inā ʻaʻole loaʻa ka lazertinib a i ʻole kūpono iā ʻoe, hiki i kekahi mau mea pale EGFR ʻē aʻe ke lilo i mau koho. Aia kēia mau mea i ka osimertinib (Tagrisso), i manaʻo pinepine ʻia ʻo ke kūlana gula no ka maʻi maʻi maʻi maʻi māmā T790M-positive.

ʻO nā koho ʻē aʻe e pili ana i ka erlotinib (Tarceva), gefitinib (Iressa), a me afatinib (Gilotrif), ʻoiai e hoʻohana pinepine ʻia kēia mau mea i nā kūlana like ʻole e pili ana i kāu mau loli maʻi maʻi kikoʻī a me ka mōʻaukala lapaʻau.

E noʻonoʻo kāu oncologist i nā mea e like me ke ʻano genetic o kāu maʻi maʻi, nā lāʻau lapaʻau i hala, ke kūlana olakino o kēia manawa, a me ka loaʻa ʻana o ka lāʻau lapaʻau i ka wā e ʻōlelo ai i nā koho ʻē aʻe. Loaʻa i kēlā me kēia o kēia mau lāʻau lapaʻau nā pōmaikaʻi a me ka ʻaoʻao hopena.

I kekahi manawa, hiki ke ʻōlelo ʻia nā lāʻau lapaʻau hui pū ʻia a i ʻole nā lāʻau lapaʻau i manaʻo ʻia ma kahi o a i ʻole me nā mea pale EGFR, ma muli o kou kūlana pilikino.

Ua ʻoi aku ka maikaʻi o Lazertinib ma mua o Osimertinib?

He mea maikaʻi nā lazertinib a me osimertinib i nā mea pale EGFR, akā ʻaʻole pono lākou e ʻoi aku ka maikaʻi a i ʻole ka ʻino ma mua o kekahi - he mau mea hana like ʻole lākou no nā kūlana like ʻole.

Ua loaʻa ʻo Osimertinib (Tagrisso) no ka lōʻihi a loaʻa nā ʻikepili lapaʻau nui e kākoʻo ana i kāna hoʻohana. ʻO ia ka koho mua no ka maʻi maʻi maʻi maʻi maʻi maʻi T790M-positive a ua hōʻike i nā hopena maikaʻi loa i nā hoʻokolohua lapaʻau.

He mea hou ʻo Lazertinib a loaʻa paha kekahi mau mea maikaʻi i kekahi mau kūlana, ʻoiai e pili ana i kona hiki ke hele i loko o ka lolo e mālama i ka maʻi maʻi i laha ma laila. Eia naʻe, pono ka noiʻi hou e hoʻohālikelike piha i ko lākou pono i ka wā lōʻihi.

E koho kāu kauka ma waena o kēia mau lāʻau lapaʻau e pili ana i kāu mau ʻano maʻi maʻi kikoʻī, nā lāʻau lapaʻau mua, ka loaʻa ʻana, a me nā mea pilikino. ʻO ka mea nui ka loaʻa ʻana o ka lāʻau lapaʻau e hana maikaʻi loa no kou kūlana.

Nā nīnau i nīnau pinepine ʻia e pili ana iā Lazertinib

Q1. Palekana ʻo Lazertinib no ka poʻe me ka maʻi puʻuwai?

Hiki i ka Lazertinib ke hoʻopilikia i ka puʻuwai, no laila pono ka poʻe me nā maʻi puʻuwai e loiloi a nānā pono. E hana paha kāu kauka i kahi EKG ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau a i kēlā me kēia manawa i ka wā o ka lāʻau lapaʻau e nānā i kou puʻuwai.

Inā he moʻolelo kou o nā pilikia o ka puʻuwai, ʻaʻole ia e hoʻokuʻu iā ʻoe mai ka lawe ʻana iā lazertinib, akā ʻo ia hoʻi e pono ʻoe e nānā kokoke. Hiki i kāu hui cardio-oncology ke hana pū e hōʻoia i ka olakino o kou puʻuwai i ka wā o ka mālama ʻana i ka maʻi maʻi.

Q2. He aha kaʻu e hana ai inā lawe hewa au i ka nui o Lazertinib?

Inā ua lawe ʻoe i ka lazertinib ma mua o ka mea i kauoha ʻia, e kelepona koke i kāu kauka a i ʻole ke kikowaena hoʻomalu lāʻau make. Mai kali e ʻike inā maikaʻi ʻoe - ʻoi aku ka maikaʻi o ka loaʻa ʻana o ka ʻōlelo aʻoaʻo lapaʻau.

ʻO ka lawe ʻana i ka nui loa o ka lazertinib hiki ke hoʻonui i kou pilikia o nā hopena ʻaoʻao koʻikoʻi, ʻo ia hoʻi nā pilikia o ka puʻuwai. E lawe mai i kāu hue lāʻau me ʻoe inā pono ʻoe e ʻimi i ka lāʻau lapaʻau i ʻike pono nā mea mālama ola i ka mea a me ka nui āu i lawe ai.

Q3. He aha kaʻu e hana ai inā e poina iaʻu kahi lāʻau o Lazertinib?

Inā e poina iā ʻoe kahi lāʻau o lazertinib, e lawe koke iā ia ke hoʻomanaʻo ʻoe, ke ʻole kokoke ka manawa no kāu lāʻau aʻe. I kēlā hihia, e lele i ka lāʻau i poina a lawe i kāu lāʻau aʻe i ka manawa maʻamau.

Mai lawe i ʻelua lāʻau i ka manawa hoʻokahi e pani ai i kahi lāʻau i poina. Inā ʻaʻole ʻoe maopopo e pili ana i ka manawa, e kelepona i kāu hui mālama ola no ke alakaʻi. Hiki iā lākou ke kōkua iā ʻoe e ʻike i ke ala maikaʻi loa e hoʻi ai i ka papa manawa me ka palekana.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Lazertinib?

Pono ʻoe e hooki i ka lawe ʻana iā lazertinib ke haʻi aku kāu kauka iā ʻoe. Hana maʻamau kēia inā holomua kāu maʻi maʻi me ka mālama ʻana, inā e hoʻomohala ʻoe i nā hopena ʻaoʻao koʻikoʻi, a i ʻole inā hoʻoholo ʻoe a me kāu kauka e hoʻololi i kahi lāʻau lapaʻau ʻē aʻe.

ʻOiai inā maikaʻi ʻoe, mai hooki i ka lawe ʻana iā lazertinib ma kāu iho. Pono ka mālama ʻana i ka maʻi maʻi i nā pae lāʻau lapaʻau kūlike e pono ai, a ʻo ka hooki ʻana i ka hiki ke ʻae i kāu maʻi maʻi e ulu wikiwiki.

Q5. Hiki iaʻu ke inu i ka waiʻona i ka wā e lawe ana iā Lazertinib?

ʻOiai ʻaʻohe pilina kikoʻī ma waena o lazertinib a me ka waiʻona, ʻoi aku ka maikaʻi o ka kaupalena ʻana i ka ʻai ʻana i ka waiʻona i ka wā o ka mālama ʻana i ka maʻi maʻi. Hiki i ka waiʻona ke hoʻonui i kekahi mau hopena ʻaoʻao e like me ka nausea a me ka luhi, a hiki ke hoʻopilikia i ka hiki o kou ate ke hana i nā lāʻau.

Inā koho ʻoe e inu i kekahi manawa, e hana pēlā me ka maʻalahi a e nānā i kou manaʻo. E kamaʻilio me kāu hui mālama ola e pili ana i ka mea kūpono no kāu kūlana kikoʻī a me ke olakino holoʻokoʻa.